| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $978.3M | +48.0% |
| Cost of Revenue | $675.0M | +57.6% |
| R&D Expense | $6.7M | +81.1% |
| SG&A Expense | $128.8M | +10.9% |
| Operating Income | $132.6M | +170.2% |
| Interest Expense | $2.6M | +6.3% |
| Pre-tax Income | $128.5M | -10.0% |
| Income Tax | $45.2M | +1718.7% |
| Net Income | $83.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $237.8M | -0.7% |
| Inventory | $248.4M | -8.4% |
| Current Assets | $728.0M | +13.5% |
| Total Assets | $1.27B | +5.9% |
| Current Liabilities | $148.2M | -8.9% |
| Long-term Debt | $18.9M | -25.6% |
| Total Liabilities | $210.6M | -12.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $190.9M | +104.3% |
| Investing Cash Flow | -$18.7M | -123.9% |
| Financing Cash Flow | -$44.9M | +56.4% |
| -40.6% |
| EPS (Basic) | $1.21 | -57.1% |
| EPS (Diluted) | $1.20 | -56.7% |
| Stockholders' Equity |
| $1.06B |
| +10.4% |